1.
Bajwa A, Maleki A, Payal AR, Fandiño A, Padrón MIM, Walsh M, Foster CS. Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy. JOVR [Internet]. 2020Oct.25 [cited 2022Sep.28];15(4):459–469. Available from: https://knepublishing.com/index.php/JOVR/article/view/7786